Inventor · disambiguated record
Claus Kremoser
Also filed as: KREMOSER CLAUS
16 granted patents·6 pending applications·285 citations·filing 2002–2024
94Inventor score
Top patents by PatentIndex Score
22 records- 0197US9539244B2FXR (NR1H4) binding and activity modulating compoundsGILEAD SCIENCES INC·Filed 2015·Granted Jan 10, 2017·28 cites·17 claims
- 0296US9751874B2Hydroxy containing FXR (NR1H4) modulating compoundsGILEAD SCIENCES INC·Filed 2015·Granted Sep 5, 2017·35 cites·12 claims
- 0395US9820979B2FXR (NR1H4) binding and activity modulating compoundsGILEAD SCIENCES INC·Filed 2016·Granted Nov 21, 2017·16 cites·6 claims
- 0494US10485795B2FXR (NR1H4) binding and activity modulating compoundsGILEAD SCIENCES INC·Filed 2019·Granted Nov 26, 2019·10 cites·18 claims
- 0594US9139539B2FXR (NR1H4) binding and activity modulating compoundsKINZEL OLAF·Filed 2012·Granted Sep 22, 2015·42 cites·10 claims
- 0693US10220027B2FXR (NR1H4) binding and activity modulating compoundsGILEAD SCIENCES INC·Filed 2017·Granted Mar 5, 2019·10 cites·16 claims
- 0793US8952042B2FXR (NR1H4) binding and activity modulating compoundsKREMOSER CLAUS·Filed 2010·Granted Feb 10, 2015·43 cites·9 claims
- 0891US11970484B2LXR modulators with bicyclic core moietyORSOBIO INC·Filed 2023·Granted Apr 30, 2024·2 cites·24 claims
- 0989US9938278B2FXR (NR1H4) modulating compoundsGILEAD SCIENCES INC·Filed 2015·Granted Apr 10, 2018·9 cites·12 claims
- 1088US8193192B2Heterocyclic FXR binding compoundsKREMOSER CLAUS·Filed 2007·Granted Jun 5, 2012·19 cites·40 claims
- 1187US7098336B2FXR NR1H4 nuclear receptor binding compoundsPHENEX PHARMACEUTICALS AG·Filed 2002·Granted Aug 29, 2006·18 cites·13 claims
- 1287US6974830B2NR1H4 nuclear receptor binding compoundsPHENIX PHARMACEUTICALS AG·Filed 2002·Granted Dec 13, 2005·32 cites·19 claims
- 1382US12291523B2LXR modulators with bicyclic core moietyORSOBIO INC·Filed 2024·Granted May 6, 2025·0 cites·2 claims
- 1482US7034046B2NR1H4 nuclear receptor binding compoundsPHENEX PHARMACEUTICALS AG·Filed 2002·Granted Apr 25, 2006·19 cites·7 claims
- 1577US11618747B2LXR modulators with bicyclic core moietyORSOBIO INC·Filed 2019·Granted Apr 4, 2023·2 cites·22 claims
- 1646US2010184809A1Heterocyclic FXR Binding CompoundsPHENEX PHARMACEUTICALS AG·Filed 2007·Application pending·0 cites
- 1745US2011263046A1Methods of identification of novel ligands for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (NR1F3) activityPHENEX PHARMACEUTICALS AG·Filed 2009·Application pending·0 cites
- 1839US2020115357A1Liver x receptors (lxr) modulatorsPHENEX FXR GMBH·Filed 2018·Application pending·0 cites
- 1937US2007010562A1Nr1h4 nuclear receptor binding compoundsBAUER ULRIKE·Filed 2002·Application pending·0 cites
- 2037US2020131144A1Amine or (thio)amide containing lxr modulatorsPHENEX FXR GMBH·Filed 2018·Application pending·0 cites
- 2134US2005261319A1Novel 2-amino-4-quinazolinones and 2-amino-4-oxoquinazolones as LXR nuclear receptor binding compounds with partial agonistic propertiesDEUSCHLE ULRICH·Filed 2005·Application pending·0 cites
- 2232US8940722B2Compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (RORγ, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune diseaseKINZEL OLAF·Filed 2011·Granted Jan 27, 2015·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Claus Kremoser files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →